FTC Chair Lina Khan (Photo by Michael Brochstein/Sipa USA)(Sipa via AP Images)
November 7, 2023 12:47 PM ESTUpdated 02:47 PM
FDA+
Law

FTC chal­lenges more than 100 drug patents owned by Ab­b­Vie, As­traZeneca, Boehringer and sev­en oth­ers

Zachary Brennan

Senior Editor

The Fed­er­al Trade Com­mis­sion on Tues­day chal­lenged more than 100 patents as im­prop­er­ly or in­ac­cu­rate­ly list­ed in the FDA’s Or­ange Book of gener­ic drugs. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Mi­crosoft-backed Enve­da rais­es $130M for drugs in I&I, obe­si­ty and oth­er ar­eas

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times